Are Formulary Decision Makers Data Needs Being Met for Specialty Drugs?

This study targeted pharmacists and physicians involved with formulary decision making in order to assess the level of satisfaction of specialty drug formulary decision makers with regards to the strength of current available data sources and unmet needs regarding clinical, economic, and unpublished evidence. See more here. (Source: JMCP Volume 22 Issue (4), April 2016)

You might also be interested in:

What Are The Recent Top 4 Innovative Consolidations and… 08/26/2020
Trump's "Buy American" Executive Order Could Raise Drug Prices 08/06/2020
AHRQ’s Registries User Guide Gets A New Edition 09/24/2020
Data Exchange for Drug Rebate Processing and Contract… 08/31/2020
Program Looks to Address Gaps in COVID-19 Data 04/14/2020
Key Innovations Coming From The Next Generation of PBM’s 08/12/2020
ICER Signs Multi-Year Deal to Use New Cloud-Based Analytic… 02/20/2020